THE BALANCEhttps://thebalance.clinic/resources/medication/buprenorphine-withdrawal/

Swiss roots. International expertise. Personal care, delivered with privacy and discretion.

THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Privacy and discretion from the first conversation.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Swiss entrepreneur · Founder & CEO

Clinical resource

Buprenorphine Withdrawal

Stopping or reducing buprenorphine can cause withdrawal after regular use. Symptoms and timing vary. A prescriber can help weigh continued treatment against a gradual reduction, with follow-up and overdose prevention when needed.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Buprenorphine is an effective treatment for opioid use disorder and may be continued long term when beneficial. Physical dependence during prescribed treatment is not the same as addiction.
  • Discuss any dose reduction with the prescriber. Withdrawal timing varies, and severe, persistent or worsening symptoms need clinical review.
  • Stopping treatment can increase the risk of returning to opioid use and overdose. Continuing care, access to medication and overdose prevention matter; suicidal intent or inability to stay safe requires emergency help.

Buprenorphine is an evidence-based medication used to treat opioid use disorder and, in some formulations, pain. In opioid use disorder treatment it can reduce withdrawal symptoms and cravings and lower the risk of overdose death. Buprenorphine can also cause physical dependence, and misuse can occur, but physical dependence during prescribed treatment is not the same as addiction. Treatment duration is individualized and may be long term or indefinite when benefits continue.

Because buprenorphine is an opioid, regular use can produce physical dependence. Abrupt discontinuation can cause withdrawal symptoms. If treatment is discontinued, a gradual plan should be agreed with the prescriber, with monitoring and opportunities to reassess. A long half-life affects withdrawal timing but does not by itself establish addiction.

Physical dependence during prescribed treatment does not automatically require detoxification. If use has become difficult to control, or you are considering a dose reduction, discuss the reasons and risks with the prescriber. The following sections explain possible withdrawal symptoms, variable timing and the support available.

Stopping buprenorphine suddenly or reducing it too quickly can cause opioid-withdrawal symptoms after regular use. The experience varies with the formulation, dose, length of treatment, other medicines or substances and the pace of reduction.

Physical symptoms

  • Sweating, hot or cold sensations and goosebumps.
  • Muscle aches or cramps, restlessness and tiredness.
  • Nausea, vomiting, abdominal discomfort or diarrhea.
  • Reduced appetite and difficulty sleeping.

Vomiting, diarrhea and sweating can contribute to dehydration. Seek medical advice if symptoms are severe or worsening, or if you cannot eat or drink adequately. Sweating is a withdrawal symptom, not a way to speed the removal of buprenorphine.

Cravings, anxiety and mood changes

Cravings, irritability, anxiety or low mood may occur during a reduction. Existing pain or mental health difficulties may also need reassessment. A new symptom should not automatically be attributed to withdrawal or assumed to be temporary.

Contact a mental-health professional or crisis service promptly for suicidal thoughts. If there is an intention to act, someone has already harmed themselves or they cannot stay safe, call local emergency services or go to an emergency department.

There is no single withdrawal timetable that applies to everyone. Symptoms may be delayed, and they do not reliably peak within 72 hours or end after a week. Some symptoms can persist for weeks; ongoing cravings or mood changes may need longer support.

What affects the timing?

Formulation, dose, duration of treatment and the pace of a taper all matter. Sublingual, buccal and long-acting injectable products are not interchangeable, and the experience after stopping them can differ.

How to monitor progress

Arrange follow-up with the prescriber rather than judging progress against a fixed week-by-week schedule. Changes in sleep, mood, pain, daily functioning and cravings can help guide review. A reduction may need to slow or pause.

Seek clinical review for severe, persistent or worsening symptoms. Risk of returning to opioid use is not confined to the withdrawal period, so continuing care and overdose prevention remain important.

Continuing effective buprenorphine treatment is a valid option. For opioid use disorder, treatment may be long term or indefinite when it remains beneficial. A wish to stop should lead to an individual discussion of benefits, risks and available support, not an automatic detox program.

If a dose reduction is chosen, the prescriber and patient agree a gradual plan with monitoring. The plan considers withdrawal symptoms, pain, mental health, other substance use, daily responsibilities and support at home. There is no universal self-directed taper that is suitable for everyone.

Psychological support, peer support and practical help can be arranged before, during and after a reduction. Follow-up should include a plan for increasing cravings or a return to opioid use, and access to ongoing or restarted medication when needed.

Stopping treatment can increase the risk of returning to opioid use and of overdose after tolerance falls. Discuss access to naloxone and an overdose-response plan. Counseling or residential support does not replace effective medication for opioid use disorder or guarantee recovery.

Questions

Frequently Asked Questions

How long does buprenorphine withdrawal last?
Withdrawal timing varies with the formulation, dose, duration of treatment and pace of any reduction. Symptoms may be delayed and can persist for weeks. Contact the prescriber for severe, persistent or worsening symptoms instead of relying on a fixed timetable.
Why should a buprenorphine dose reduction involve the prescriber?
Supervision is important when a dose reduction is chosen, but physical dependence on prescribed buprenorphine does not automatically require detox. For opioid use disorder, treatment may continue long term or indefinitely while beneficial. Discuss any taper with the prescriber, including withdrawal support, follow-up, access to naloxone and the option to continue or restart treatment. Stopping can increase the risk of return to opioid use and overdose.
Can I detox from Subutex at home?
The appropriate setting for a buprenorphine dose reduction depends on the reason for treatment, medical and psychiatric risk, other substance use, housing and support, and the person’s preferences. Many stable patients can be managed as outpatients with prescriber follow-up; residential or hospital care is reserved for situations that require a higher level of support. Do not stop buprenorphine abruptly without discussing the plan with the prescriber. For people taking it for opioid use disorder, discontinuation can increase the risk of return to opioid use and overdose after tolerance falls, so continuing medication may be safer than tapering for some people.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

02SAMHSA. TIP 63: Medications for Opioid Use Disorder.View source
View all 4 sourcesShow fewer sources
04FDA. Safety advice for buprenorphine medicines dissolved in the mouth.View source
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care